Mohammed T, Parekh T, Desai A. Cardiovascular risk management in cancer survivors: Are we doing it right? World J Clin Oncol 2021; 12(3): 144-149 [PMID: 33767970 DOI: 10.5306/wjco.v12.i3.144]
Corresponding Author of This Article
Aakash Desai, MBBS, Postdoctoral Fellow, Department of Hematology and Oncology, Mayo Clinic, Rochester, MN 55902, United States. adesaimd@outlook.com
Research Domain of This Article
Oncology
Article-Type of This Article
Opinion Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Oncol. Mar 24, 2021; 12(3): 144-149 Published online Mar 24, 2021. doi: 10.5306/wjco.v12.i3.144
Cardiovascular risk management in cancer survivors: Are we doing it right?
Turab Mohammed, Tarang Parekh, Aakash Desai
Turab Mohammed, Department of Medicine, University of Connecticut, Farmington, CT 06030, United States
Tarang Parekh, Department of Health Administration and Policy, George Mason University, Fairfax, VA 22030, United States
Aakash Desai, Department of Hematology and Oncology, Mayo Clinic, Rochester, MN 55902, United States
Author contributions: Mohammed T and Desai A contributed to the conception and design, provision of study material or patients; all authors contributed to the collection and assembly of data, data analysis, and interpretation of manuscript writing and final approval of the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Aakash Desai, MBBS, Postdoctoral Fellow, Department of Hematology and Oncology, Mayo Clinic, Rochester, MN 55902, United States. adesaimd@outlook.com
Received: December 16, 2020 Peer-review started: December 16, 2020 First decision: January 7, 2021 Revised: January 12, 2021 Accepted: February 12, 2021 Article in press: February 12, 2021 Published online: March 24, 2021 Processing time: 84 Days and 21.7 Hours
Abstract
Although under-recognized, cancer survivors continue to be at an increased risk of death from cardiovascular complications post-remission or cure. This increased burden of cardiovascular disease results from the interplay of various factors. Adequate cardiovascular risk assessment and timely intervention through a multi-disciplinary approach in these patients plays a pivotal role in the prevention of cardiovascular morbidity and mortality. We discuss the shortcomings of using current risk prediction scores in cancer survivors and provide some insights into cardiovascular risk management relevant for primary care physicians, oncologists, and cardiologists alike.
Core Tip: Accurate assessment of cardiovascular risk in adult cancer survivors is important. Cancer survivors form a unique subset of a vulnerable population given their exposures to potential cardiotoxic therapies. The importance of common preventive cardiovascular strategies in the long-term outcomes of cancer survivors is understated in clinical practice.
